Differential importance of endothelial and hematopoietic cell GLP-1Rs for cardiometabolic versus hepatic actions of semaglutide
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Differential importance of endothelial and hematopoietic cell GLP-1Rs for cardiometabolic versus hepatic actions of semaglutide
Authors
Keywords
-
Journal
JCI Insight
Volume 6, Issue 22, Pages -
Publisher
American Society for Clinical Investigation
Online
2021-10-22
DOI
10.1172/jci.insight.153732
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Effect of Exenatide Once Weekly on Carotid Atherosclerosis in Individuals With Type 2 Diabetes: An 18-Month Randomized Placebo-Controlled Study
- (2021) Juraj Koska et al. DIABETES CARE
- Effects of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination on the Atherosclerosis-Related Process in a Type 2 Diabetes Mouse Model
- (2021) Jin Hee Kim et al. Endocrinology and Metabolism
- The changing landscape of atherosclerosis
- (2021) Peter Libby NATURE
- TCF7 is not essential for glucose homeostasis in mice
- (2021) Kiran Deep Kaur et al. Molecular Metabolism
- Meta-Analysis of Leukocyte Diversity in Atherosclerotic Mouse Aortas
- (2020) Alma Zernecke et al. CIRCULATION RESEARCH
- Loss of Glp2r signaling activates hepatic stellate cells and exacerbates diet-induced steatohepatitis in mice
- (2020) Shai Fuchs et al. JCI Insight
- Hematopoietic vs. enterocyte-derived dipeptidyl peptidase-4 differentially regulates triglyceride excursion in mice
- (2020) Elodie M. Varin et al. JCI Insight
- Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation
- (2020) Brent A McLean et al. ENDOCRINE REVIEWS
- Using a reporter mouse to map known and novel sites of GLP-1 receptor expression in peripheral tissues of male mice
- (2020) Daniel B Andersen et al. ENDOCRINOLOGY
- Gut intraepithelial T cells calibrate metabolism and accelerate cardiovascular disease
- (2019) Shun He et al. NATURE
- Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study
- (2019) Angelo Maria Patti et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Anti-atherogenic effects of liraglutide in hyperglycemic apolipoprotein E-null mice via AMP-activated protein kinase independent mechanisms
- (2019) Masakazu Koshibu et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Liraglutide attenuates pre-established atherosclerosis in apolipoprotein E deficient mice via regulation of immune cell phenotypes and pro-inflammatory mediators
- (2019) Robyn Bruen et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Glucagon-like peptide 1 (GLP-1)
- (2019) T.D. Müller et al. Molecular Metabolism
- Endothelial GLP-1 (Glucagon-Like Peptide-1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension
- (2019) Johanna Helmstädter et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Single-cell RNA sequencing of mouse brain and lung vascular and vessel-associated cell types
- (2018) Liqun He et al. Scientific Data
- Discovery, characterization, and clinical development of the glucagon-like peptides
- (2017) Daniel J. Drucker et al. JOURNAL OF CLINICAL INVESTIGATION
- Sex differences in the LDL receptor knockout mouse model of atherosclerosis
- (2017) Neel A. Mansukhani et al. Artery Research
- A single injection of gain-of-function mutant PCSK9 adeno-associated virus vector induces cardiovascular calcification in mice with no genetic modification
- (2016) Claudia Goettsch et al. ATHEROSCLEROSIS
- Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study
- (2016) Manfredi Rizzo et al. Cardiovascular Diabetology
- The Cardiovascular Biology of Glucagon-like Peptide-1
- (2016) Daniel J. Drucker Cell Metabolism
- Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis
- (2016) Michael A. Gimbrone et al. CIRCULATION RESEARCH
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- GLP-1R Agonists Modulate Enteric Immune Responses Through the Intestinal Intraepithelial Lymphocyte GLP-1R
- (2015) Bernardo Yusta et al. DIABETES
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oxyntomodulin regulates resetting of the liver circadian clock by food
- (2015) Dominic Landgraf et al. eLife
- Induction of Atherosclerosis in Mice and Hamsters Without Germline Genetic Engineering
- (2014) Martin Mæng Bjørklund et al. CIRCULATION RESEARCH
- Glucagon-Like Peptide-1 Receptor Agonists Increase Pancreatic Mass by Induction of Protein Synthesis
- (2014) Jacqueline A. Koehler et al. DIABETES
- GLP-1 Receptor Localization in Monkey and Human Tissue: Novel Distribution Revealed With Extensively Validated Monoclonal Antibody
- (2014) Charles Pyke et al. ENDOCRINOLOGY
- Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration
- (2013) Y Wang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Identification and Characterization of GLP-1 Receptor-Expressing Cells Using a New Transgenic Mouse Model
- (2013) P. Richards et al. DIABETES
- Vertical Sleeve Gastrectomy Is Effective in Two Genetic Mouse Models of Glucagon-Like Peptide 1 Receptor Deficiency
- (2013) H. E. Wilson-Perez et al. DIABETES
- The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE−/− mouse model
- (2013) Tracey Gaspari et al. Diabetes & Vascular Disease Research
- GLP-1 Receptor Activation Indirectly Reduces Hepatic Lipid Accumulation But Does Not Attenuate Development of Atherosclerosis in Diabetic MaleApoE−/−Mice
- (2012) Naim Panjwani et al. ENDOCRINOLOGY
- Glucagon-like peptide-1 receptor signalling selectively regulates murine lymphocyte proliferation and maintenance of peripheral regulatory T cells
- (2010) I. Hadjiyanni et al. DIABETOLOGIA
- The contribution of the Tie2+ lineage to primitive and definitive hematopoietic cells
- (2010) Yuefeng Tang et al. GENESIS
- Glucagon-Like Peptide-1 Receptor Activation Modulates Pancreatitis-Associated Gene Expression But Does Not Modify the Susceptibility to Experimental Pancreatitis in Mice
- (2009) J. A. Koehler et al. DIABETES
- CCR6 and NK1.1 distinguish between IL-17A and IFN-γ-producing γδ effector T cells
- (2009) Jan D. Haas et al. EUROPEAN JOURNAL OF IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started